175 related articles for article (PubMed ID: 8644025)
1. [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
Kukushkin SK; Shamarin VM; Manoshkina EM; Berzak NV; Petrosian KIu
Ter Arkh; 1996; 68(1):29-30. PubMed ID: 8644025
[No Abstract] [Full Text] [Related]
2. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
3. [The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
Runovich AA; Verkhozin IA; Kuril'skaia TE; Zuev AV
Ter Arkh; 1997; 69(9):51-2. PubMed ID: 9411828
[No Abstract] [Full Text] [Related]
4. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
[TBL] [Abstract][Full Text] [Related]
6. [The physicochemical properties of molsidomine preparations and their efficacy in treating IHD and circulatory failure].
Körner A; Ol'binskaia LI; Sizova ZhM; Morozov IuA
Ter Arkh; 1995; 67(8):25-7. PubMed ID: 7482326
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
Korabel'shchikova NI; Rishko NV; Bichko MV
Vrach Delo; 1985 Aug; (8):19-21. PubMed ID: 3840931
[No Abstract] [Full Text] [Related]
8. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
[No Abstract] [Full Text] [Related]
9. [Effectiveness of using corvaton on patients with unstable stenocardia].
Vakaliuk IP
Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
[No Abstract] [Full Text] [Related]
10. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms].
Metelitsa VI; Kokurina EV; Martsevich SIu; Urumbaev RK; Slastnikova ID
Ter Arkh; 1989; 61(8):27-30. PubMed ID: 2511641
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
13. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
Bondarenko IP; Tkachev VA
Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
[TBL] [Abstract][Full Text] [Related]
14. [A comparative evaluation of the antianginal action of commercially and noncommercially produced validol in neurocirculatory dystonia and stenocardia].
Bondarenko IP; Liashenko MM; Chirkov SN; Ermakovich II
Lik Sprava; 1996; (3-4):110-3. PubMed ID: 9035841
[TBL] [Abstract][Full Text] [Related]
15. [The therapeutic effect of nitromint retard on patients with stable angina pectoris].
Tsekov Kh; Karastatev D; Mazhdrakova D; Georgieva Zh; Ginkova Ia; Todorov B; Dermendzhieva R; Rangochev B
Vutr Boles; 1990; 29(1):39-43. PubMed ID: 2118701
[TBL] [Abstract][Full Text] [Related]
16. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies.
Messin R; Cerreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Adv Ther; 2006; 23(1):107-30. PubMed ID: 16644612
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].
Blagodatskikh SV; Martsevich SIu; Metelitsa VI; Kutishenko NP; Kozyreva MP; Simkhaev LS; Slastinkova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1995; 58(3):25-7. PubMed ID: 7663289
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities.
Messin R; Dubois C; Famaey JP
Adv Ther; 2008 Nov; 25(11):1200-14. PubMed ID: 19002405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
